A Randomized Crossover Clinical Trial to Evaluate the Efficacy of Oral Transmucosal Fentanyl Citrate in the Treatment of Dyspnea on Exertion in Patients With Advanced Cancer
Conclusion:
It could not be demonstrated that the OTFC improved exertion dyspnea in patients with advanced cancer. A placebo effect was observed in all the patients.
Source: American Journal of Hospice and Palliative Medicine - Category: Palliative Care Authors: Pinna, M. A. C., Bruera, E., Moralo, M. J. R., Correas, M. A. S., Vargas, R. M. Tags: Original Articles Source Type: research
More News: Actiq | Cancer | Cancer & Oncology | Clinical Trials | Fentanyl | Lung Cancer | Morphine | Oral Cancer | Palliative | Palliative Care